IVACC fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Intervacc AB engages in the development of novel veterinary vaccines. It markets veterinary vaccines through its subsidiary Nordvacc Läkemedel AB. The company was founded by Jan-Ingmar Flock, Bengt Guss, Kenneth Janzon, and Rune Bergman in 2001 and is headquartered in Stockholm, Sweden.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
IVACC has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company